Jason Brandt - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Jason Brandt’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Health Care,
- Telecommunications,
- Hospitals,
- Data Science,
- Healthcare Delivery,
- Wellness,
- Women Founded,
- Enterprise Software,
- Outpatient Care,
- Healthcare Innovation,
- Life Science,
- Portfolio Management,
- Medical Technologies,
- Information Services,
- Information Technology (IT),
- Venture Fundraising,
- Technology,
- Finance,
- Software,
- Biotechnology,
- Medical Devices,
- Hispanic / Latinx Founded,
- Productivity Software,
- Landscaping,
- Clinical Trials,
- Disruptive technology,
- Natural Language Processing,
- Consumer Software,
- Health Diagnostics,
- Medical,
- Big Data,
- Information Technology,
- B2B,
- Therapeutics,
- Health Tech,
- Media and Entertainment,
- Machine Learning,
- Cosmetic Surgery,
- Pharmaceuticals,
- Healthcare Technology
Social media:
Past investments:
- HNI Healthcare
- Ketra
- Healthcare Highways
- Nirogy Therapeutics
- Claret Medical
- Iterion Therapeutics
- Zeno Corporation
- Terapio
- RiseHealth
- Rex Bionics
- Renascent Medical
- Lumos Pharma
- Explorys
- Protein Discovery
- Guided Interventions
- Farapulse
- LumaTherm
- Geneos Therapeutics
- Deutsche Bank
- TVA Medical
- kēlaHealth
- Spinal Restoration
- Hedgeworks LLC
- DyaMX
- BioStable
- Cryosa
- Lyric Pharmaceuticals
- BAROnova
- Millipede
- Molecular Templates
- Mirna Therapeutics
- AbVitro
- Remedy
- Libra Therapeutics
- EndoStim
- Glyscend
- Laguna Pharmaceuticals
Investor Profile
Jason Brandt is a Venture Capital, Private Equity Firm based in San Diego, California, United States with a diverse investment portfolio that includes companies such as HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics, Claret Medical, Iterion Therapeutics, Zeno Corporation, Terapio, RiseHealthRex Bionics, Renascent Medical, Lumos Pharma, Explorys, Protein Discovery, Guided Interventions, Farapulse, LumaTherm, Geneos Therapeutics, Deutsche Bank, TVA Medical, kēlaHealth, Spinal Restoration, Hedgeworks LLC, DyaMX, BioStable, Cryosa, Lyric Pharmaceuticals, BAROnova, Millipede, Molecular Templates, Mirna Therapeutics, AbVitro, Remedy, Libra Therapeutics, EndoStim, Glyscend, Laguna Pharmaceuticals, . Over time, Jason Brandt has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Jason Brandt is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Telecommunications, Hospitals, Data Science, Healthcare Delivery, Wellness, Women Founded, Enterprise Software, Outpatient Care, Healthcare Innovation, Life Science, Portfolio Management, Medical Technologies, Information Services, Information Technology (IT), Venture Fundraising, Technology, Finance, Software, Biotechnology, Medical Devices, Hispanic / Latinx Founded, Productivity Software, Landscaping, Clinical Trials, Disruptive technology, Natural Language Processing, Consumer Software, Health Diagnostics, Medical, Big Data, Information Technology, B2B, Therapeutics, Health Tech, Media and Entertainment, Machine Learning, Cosmetic Surgery, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with Jason Brandt, as their portfolio suggests a familiarity and interest in this area.
Understanding Jason Brandt’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
